Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Market Cap	2.78B
Revenue (ttm)	1.42B
Net Income (ttm)	87.72M
Shares Out	23.66M
EPS (ttm)	3.71
PE Ratio	31.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,418
Average Volume	3,462
Open	118.00
Previous Close	117.32
Day's Range	118.00 - 123.18
52-Week Range	69.00 - 202.06
Beta	0.14
RSI	37.32
Earnings Date	Feb 9, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 406
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BAFNAPH

Financial Performance

In 2024, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.53 million, a decrease of -43.49%.